# Effects of Fatty Acid Supplementation on Substance Dependent Individuals

> **NCT00312455** · PHASE2 · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)**

## Conditions studied

- Substance-related Disorders

## Interventions

- **DRUG:** Pro-eicosapentaenoic acid (EPA)
- **DRUG:** Pro-docosapentaenoic acid (DPA)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00312455
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2005-07
- **Final completion:** 2005-07
- **Target enrollment:** — (—)
- **Last updated:** 2017-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00312455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00312455, "Effects of Fatty Acid Supplementation on Substance Dependent Individuals". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00312455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*